Koyfin Home > Directory > Health Care > Biogen Inc > Long-Term Investments

Biogen Inc Long-Term Investments Chart (BIIB)

Biogen Inc annual/quarterly Long-Term Investments from 2010 to 2020.
  • Biogen Inc Long-Term Investments for the quarter ending September 09, 2020 was $2,842m a 6.39% increase of 182m year over year
  • Biogen Inc Long-Term Investments for the last 12 months ending September 09, 2020 was $2,842m a 6.39% increase of 182m year over year
  • Biogen Inc Annual Long-Term Investments for 2019 was $2,661m a -14.99% decrease of -399m from 2018
  • Biogen Inc Annual Long-Term Investments for 2018 was $3,060m a -13.27% decrease of -406m from 2017
  • Biogen Inc Annual Long-Term Investments for 2017 was $3,466m a -18.90% decrease of -655m from 2016
Other Cash Flow Metrics:
  • Biogen Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $1,736m a 12.54% increase of 218m year over year
  • Biogen Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,098m a 0.14% increase of 2m year over year
  • Biogen Inc Total Revenue for the quarter ending December 12, 2018 was $3,526m a 11.21% increase of 395m year over year
View Chart On Koyfin

Quarterly BIIB Long-Term Investments Data

09/2020$2,842m
06/2020$2,405m
03/2020$2,096m
12/2019$2,661m
09/2019$3,045m
06/2019$2,615m
03/2019$3,271m
12/2018$3,060m
09/2018$2,239m
06/2018$2,041m

Annual BIIB Long-Term Investments Data

2019$2,661m
2018$3,060m
2017$3,466m
2016$4,121m
2015$3,828m
2014$2,211m
2013$1,203m
2012$2,293m
2011$1,622m
2010$946m